| Resveratrol |
Flow cytometry |
Flow cytometry |
10.00 µM |
MG-63 |
Homo sapiens |
|
|
|
| Resveratrol |
Flow cytometry |
Flow cytometry |
10.00 µM |
MNNG/HOS |
Homo sapiens |
|
|
|
| Resveratrol |
Flow cytometry |
Flow cytometry |
20.00 µM |
MG-63 |
Homo sapiens |
|
|
|
| Resveratrol |
Flow cytometry |
Flow cytometry |
20.00 µM |
MNNG/HOS |
Homo sapiens |
|
|
|
| Resveratrol |
Flow cytometry |
Flow cytometry |
40.00 µM |
MG-63 |
Homo sapiens |
|
|
|
| Resveratrol |
Flow cytometry |
Flow cytometry |
40.00 µM |
MNNG/HOS |
Homo sapiens |
|
|
|
| Resveratrol |
Influence on cell cycle |
Flow cytometry |
50.00 µM |
MM1 |
Homo sapiens |
|
|
|
| Resveratrol |
Influence on cell apoptosis |
Flow cytometry- annexin V binding and propidium iodide staining |
40.00 µM |
MG-63 |
Homo sapiens |
|
|
|
| Resveratrol |
Influence on cell apoptosis |
Flow cytometry- annexin V binding and propidium iodide staining |
40.00 µM |
MNNG/HOS |
Homo sapiens |
|
|
|
| Resveratrol |
Influence on cell apoposis in presence of Bortezomib |
Flow cytometry- annexin V binding and propidium iodide staining |
25.00 µM |
Enriched CD138+ |
Homo sapiens |
|
|
|
